Status:
UNKNOWN
International Low Anterior Resection Score Evaluation
Lead Sponsor:
National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos
Collaborating Sponsors:
King's College London
National Cancer Institute (NCI)
Conditions:
Low Anterior Resection Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
* Aim: The aim of this study is to perform a prospective, international 4 months cohort study evaluating bowel function before curative rectal cancer surgery and one year after the surgery using the L...
Detailed Description
All patients undergoing treatment for rectal rectal will be included in the study. Before any treatment all the included patients will be asked to fill the LARS score (5 question questionnaire with di...
Eligibility Criteria
Inclusion
- Patients undergoing rectal cancer surgery on curative intent.
- Elective surgery patients.
- Laparoscopic, laparoscopic-converted, robotic, TaTME (transanal total mesorectal excision) and open cases will be included.
- Patients aged 18 years and over should be included.
Exclusion
- Patients undergoing a procedure purely for diagnosis or staging should be excluded.
- Patients with palliative treatment.
- Patients with recurrence should be excluded.
- Patients with dementia
- Patients who do not complete their treatment within 12 months of primary surgery e.g. including reversal of stoma, chemotherapy etc
Key Trial Info
Start Date :
September 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04040842
Start Date
September 1 2019
End Date
December 31 2023
Last Update
November 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute
Vilnius, Lithuania, 08406